INTRODUCTION {#sec1-1}
============

Atypical teratoid/rhabdoid tumor (AT/RT) is predominantly a childhood tumor and has only been rarely reported in adults.

The exact incidence of AT/RT is unknown. It occurs predominantly in infants less than 3 years of age.\[[@ref28][@ref32]\] It is believed that AT/RT accounts for 1-2% of pediatric brain tumors and over 10% of central nervous system (CNS) tumors in infants, with a male preponderance up to the age of 3, which then seems disappear.\[[@ref32][@ref38]\] Adult cases are rare and, as far as we are aware, only 42 cases have been reported to date \[[Table 1](#T1){ref-type="table"}\].\[[@ref2][@ref3][@ref4][@ref5][@ref9][@ref10][@ref11][@ref12][@ref13][@ref14][@ref15][@ref16][@ref17][@ref18][@ref21][@ref23][@ref24][@ref25][@ref26][@ref27][@ref29][@ref30][@ref31][@ref33][@ref34][@ref35][@ref36][@ref37][@ref39][@ref41]\] Furthermore, there are only seven adult cases arising in the sellar turcica described in the literature.\[[@ref2][@ref24][@ref25][@ref30][@ref34]\]

###### 

Adult patients with atypical teratoid/rhabdoid tumor in the central nervous system

![](SNI-5-75-g001)

Here we present a case of a 44-year-old female with a AT/RT in sellar turcica who complained of visual disturbance. We performed craniotomies twice and removed partially for each time, but any malignant cells were not found in the specimens. Finally, we determined histological diagnosis from the extended lesion. It is the first case that AT/RT was diagnosed from the extended lesion and we detailed our case with a thorough literature review.

CASE REPORT {#sec1-2}
===========

A previously healthy 44-year-old female presented with a 2-month history of visual disturbance. Magnetic resonance imaging (MRI) revealed a heterogeneously enhancing mass within suprasellar and intrasellar lesions \[[Figure 1](#F1){ref-type="fig"}\]. She underwent a partial resection, mainly caudal part of the tumor, via translabial transsphenoidal approach \[[Figure 2](#F2){ref-type="fig"}\]. As the pathological examination could not find any malignant cells, histological diagnosis from this operation was lymphocytic hypophisitis.

![T1-weighted MRI coronal (a) and sagittal (b) images clearly show inhomogeneously gadolinium enhancing mass in sellar turcica extending into suprasellar lesion](SNI-5-75-g002){#F1}

![T1-weighted MR coronal (a) and sagittal (b) images show a partial removal of the tumor after the first operation via translabial transsphenoidal approach](SNI-5-75-g003){#F2}

Steroid pulse therapy was performed, but 2 months after the first operation, bilateral abducens paralysis was noticed. The second partial resection was performed, mainly ventral and rostral part of the tumor, via a basal interhemispheric approach \[[Figure 3](#F3){ref-type="fig"}\], and malignant cells were not found from the surgical specimen \[[Figure 4](#F4){ref-type="fig"}\]. Despite the aggressive therapies with immunosuppressant and radiotherapy for the lesion, she lost her vision in the left eye within a few months. MRI demonstrated the expansion of the lesion to the left cavernous sinus, the left orbital fossa and the left forehead with no regrowth in the sellar region \[[Figure 5](#F5){ref-type="fig"}\]. Furthermore, intracranial dissemination and distant metastasis were found in the right cerebellar hemisphere, vermis, spinal cord, and lung \[[Figure 6](#F6){ref-type="fig"}\]. Biopsies were performed at the left orbital fossa and the left forehead and histological diagnosis was AT/RT. Three drug chemotherapies were performed at 3-week intervals for a total of five cycles. Each cycle consisted of ifosfamide, cisplatin, and etoposide administered on days 1-5. Radiotherapy was given. She died of respiratory failure 17 months after the initial treatment.

![T1-weighted MR coronal (a) and sagittal (b) images show a partial removal of the tumor after the second operation via a basal interhemispheric approach](SNI-5-75-g004){#F3}

![Photomicrographs of tumor specimens obtained in the patient from the first operation. There was no malignant cells. H and E. Original magnification ×100 (a) and ×400 (b)](SNI-5-75-g005){#F4}

![T1-weighted MR coronal (a) and sagittal (b) images show an aggressive extension to the left cavernous sinus, the left orbital fossa and the left forehead with no regrowth in the sellar region](SNI-5-75-g006){#F5}

![T1-weighted MR images (a-c) and contrast computed tomography image (d) show intracranial dissemination (arrow head) and distant metastasis in the lung (arrow head)](SNI-5-75-g007){#F6}

Histopathological findings {#sec2-1}
--------------------------

The tumor was composed of polygonal cells with a relatively high nuclear/cytoplasm ratio and the rhabdoid cells had medium, round, single or double nuclei, and eosinophilic cytoplasmic inclusions. The tumor cells showed strong immunoreactivity for O-6 methylguanine DNA methyltransferase (MGMT), Nestin and S100 protein, and focal positivity for epithelial membrane antigen (EMA) and Glypican-3. Desmin, oligodendrocyte transcription factor 2 (oligo2), placentral alkaline phosphatase, myogenin and p63 were negative. Proliferative activity is high, and Ki-67/MIB-1 labeling index was more than 90%. Since the tumor cells lacked nuclear expression of INI1, the tumor was pathologically diagnosed as AT/RT \[[Figure 7](#F7){ref-type="fig"}\].

![Histologically, the tumor tissue is mainly composed of hyperchromatic small cells with a relatively high nuclear/cytoplasm ratio and rhabdoid cells (H and E. Original magnification ×100 (a) and ×400 (b)). In immunohistochemical studies, Nestin (c), S-100 (d) and Vimentin (e) were positive and EMA (f) was focally positive. The proliferation index measured by Ki-67 was 85% in the areas of highest mitotic activity (g) and the tumor cells lack nuclear staining for the INI1 protein (h). Pathological findings were consistent with those of atypical teratoid/rhabdoid tumor](SNI-5-75-g008){#F7}

DISCUSSION {#sec1-3}
==========

In 1978, Beckwith and Palmer first documented the rhabdoid tumor, which occurred in the kidney, with the variant of the Wilm\'s tumor found in the kidneys of children.\[[@ref6]\] Rorke *et al*. first recognized this tumor in the CNSs under the term AT/RT to emphasize the variable combination of rhabdoid cells, epithelial cells, primitive neuroectodermal as well as mesenchymal components. Since they defined the clinical and pathological features of AT/RT in 1996, based on data from 52 infants and children, this unique neoplasm has been widely recognized and currently constitutes one of three major embryonal tumor entities according to the 2007 World Health Organization classification of CNS tumors.\[[@ref32]\]

It is more frequently seen in infants and young children and is rare in adults.\[[@ref28][@ref32][@ref38]\] Forty-one cases of adults with AT/RT have been published to date \[[Table 1](#T1){ref-type="table"}\]. The mean age of patients at diagnosis was 32.1 years, with a range of 18-61 years, and there were 21 males and 20 females. Thirty-four cases were supratentorial in location with 7 cases in the sellar region and 3 cases in the pineal region, 4 cases were infratentorial, and 3 cases were spinal cord. Clinical data and clinicopathological features of all adult cases and our case are summarized in [Table 1](#T1){ref-type="table"}. Occurrence of AT/RT in the sellar region is rare and all seven adult patients with sellar AT/RT were female, with ages from 20 to 61 years. In contrast, the sellar region has never been reported to give rise to AT/RT in pediatric patients.

In immunohistochemical studies, rhabdoid cells are usually positive for vimentin, epithelical membrane antigen, cytokeratin, and smooth muscle actin. Markers for germ-cell tumors such as alpha-fetoprotein and placental alkaline phosphatase are consistently negative. Loss of expression of INI-1 correlates with mutation of the INI1 tumor suppressor gene (the hSNF5/INI1 gene), which maps to the 22q11.2 locus and is a sensitive and specific marker.\[[@ref1][@ref7][@ref22][@ref37][@ref40]\] Immunohistochemical study using antibody against the INI1 gene product or FISH to identify loss of the INI1 locus is the current routine workup for diagnostic confirmation of AT/RT.\[[@ref8][@ref19][@ref20][@ref32]\] In our case, EMA was positive, and INI1 and desmin were negative. Pathological findings were consistent with those of AT/RT.

AT/RT is characterized by an aggressive clinical behavior in most pediatric patients, who usually die within approximately one year after the diagnosis despite aggressive therapy, while adult patients are reportedly better with some longer-term survivors.\[[@ref36]\] A recent report suggest that cerebral location of an AT/RT renders the tumor amenable to gross total resection as well as aggressive adjuvant chemoradiation therapy available in adults, which would not be tolerated by small children.\[[@ref35]\] Therefore, immunohistochemical verification of this entity is very important for a proper treatment and better prognosis and AT/RT must be considered in the diagnosis of a high-grade tumor regardless of age.

In this case, we could not find any malignant cell in surgical specimens taken at two operations. The histological diagnosis was finally made from the extended site. Although there is a discrepancy between histologies, but it is natural that the lesions of left cavernous sinus, left orbital fossa and left forehead were consistently extended from the sellar turcica. This inference is confirmed by the fact that AT/RT show a greater tendency to disseminate intracranially and metastasize extracranially.\[[@ref28]\] Partial resection might make it possible to extend and metastasize. Takahashi *et al*. reported a case that the histological findings had changed during 9 years.\[[@ref36]\] However, it has never been reported that AT/RT was diagnosed from the extended lesion.

CONCLUSION {#sec1-4}
==========

Although extremely rare and usually fatal, AT/RT should be considered in the differential diagnosis of an unclear malignant sellar lesion in adult patients. It is important to perform a total resection of such tumors followed by chemotherapy and radiation therapy to afford patients a better prognosis. However AT/RT is rare in adults, the appropriate immunohistochemical evaluation should be performed to diagnose this rare entity.
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